InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Tanini Annita. Director active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 1 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €11k. History available since 18 August 2026. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条